Although the gene TP53 is almost always unaltered in retinoblastoma, the negative regulator MDM2 and its homolog MDM4 may be overexpressed, blocking the transcriptional activity and stimulating degradation of the p53 protein (120). The gene discussed is MDM4; the disease is retinoblastoma.